Diclofenac Sodium
API
Diclofenac Sodium grades are available to suit a wide range of formulations requiring precise control over the release rate
Diclofenac Sodium grades are available to suit a wide range of formulations requiring precise control over the release rate
Diclofenac Sodium is a vital Active Pharmaceutical Ingredient (API) belonging to the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) class. It is characterized by its powerful triple action: Analgesic (pain relief), Anti-inflammatory, and Antipyretic (fever reduction). Diclofenac Sodium is a key choice for immediate-release, extended-release, and topical formulations, with high demand for managing various pain and inflammatory conditions.
Immediate-release, extended-release, and enteric-coated tablets.
Supplied in grades with enhanced flow and compressibility characteristics for high-speed tableting, recognizing the need for Enteric Coating for gastric protection.
Gels, creams, and topical solutions for localized pain relief.
Good solubility and dispersibility in dermal bases for producing highly effective topical products.
Intramuscular (IM) injection solutions and rectal suppositories.
Availability of high-purity grades meeting sterility requirements (for injectables) and stability in fatty bases (for suppositories).
The product conforms to the specified requirements of the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and/or British Pharmacopoeia (BP).
A detailed CoA is issued with every batch, outlining potency, purity profile, and microbiological testing verification.
A comprehensive Drug Master File is available to support registration submissions to regulatory authorities worldwide.
Production takes place in certified facilities that strictly adhere to current Good Manufacturing Practices (cGMP).